Today: 19 April 2026
Sandisk stock price rises ahead of earnings as AI storage trade stays in focus (SNDK)

Sandisk stock price rises ahead of earnings as AI storage trade stays in focus (SNDK)

NEW YORK, Jan 29, 2026, 09:54 EST — Regular session

  • Sandisk shares rose about 1% in early trading ahead of fiscal second-quarter results due after the close.
  • Storage peers Seagate and Western Digital were higher, while Micron edged lower.
  • Investors are looking for clues on NAND pricing and data-center demand in Sandisk’s outlook.

Sandisk shares ticked higher on Thursday morning as investors positioned for the flash-memory maker’s quarterly update due after U.S. markets close.

The report lands at a touchy moment for memory and storage stocks, where rallies have fed on the idea that AI data centers are soaking up NAND flash memory — the storage chips used in solid-state drives and phones — faster than suppliers can add capacity.

That leaves the company’s tone on pricing, supply and 2026 demand doing as much work as the numbers.

Sandisk was up about 1.0% at $532.99, after trading as high as $547 and as low as $523. Seagate rose about 2.0%, Western Digital gained 0.2% and Micron slipped 0.1%.

The group has taken cues from Seagate, which on Tuesday reported $2.83 billion in fiscal second-quarter revenue and non-GAAP profit of $3.11 a share, and forecast a stronger March quarter. “Seagate’s December quarter results exceeded our expectations on both the top and bottom line,” CEO Dave Mosley said. Seagate Investor Relations

Some analysts are still chasing the move. Lynx Equity raised its price target on Sandisk to $750 from $300, citing tight NAND supply and limited meaningful supply additions before 2028, Investing.com reported.

Sandisk has said it will hold its fiscal second-quarter earnings conference call at 1:30 p.m. Pacific time on Thursday.

On average, analysts are looking for revenue of about $2.7 billion and adjusted earnings per share of $3.62, Barron’s reported. The stock has gained roughly 1,237% since its February 2025 listing after Western Digital spun off the business, the publication said.

Supply remains the wild card. Micron this week broke ground on an advanced wafer fab at its Singapore NAND complex in a planned investment of about $24 billion over 10 years, with wafer output scheduled to start in the second half of 2028. “Micron’s leadership in advanced memory and storage is enabling the AI-driven transformation reshaping the global economy,” Micron executive vice president Manish Bhatia said. Micron Technology

TrendForce analyst Bryan Ao told Reuters that demand for high-performance storage has been growing faster than expected as AI inference expands, and he expects contract prices for enterprise solid-state drives to rise 55% to 60%.

But memory markets turn fast. A pause in cloud spending, or a wave of new supply landing earlier than expected, can pressure flash prices and squeeze margins.

Traders will watch Sandisk’s results after the bell and listen for any change in management’s view on NAND pricing, data-center demand and the 2026 supply outlook.

Stock Market Today

  • Brown-Forman (BF.B) Faces Valuation Debate After Strong Short-Term Rally
    April 18, 2026, 9:26 PM EDT. Brown-Forman's (BF.B) stock surged about 27% in one month, reversing last year's roughly 11% decline. The recent sharp rebound contrasts with a weaker long-term trend, highlighting momentum shifts. Despite shares trading near analyst price targets at $29.15, fair value estimates diverge widely. Simply Wall St's discounted cash flow (DCF) model values Brown-Forman at $37.78, suggesting undervaluation, while another model pegs fair value at $21.00, indicating the stock is roughly 39% overvalued. The gap reflects differing views on declining global alcohol consumption due to rising health awareness, which could pressure Brown-Forman's revenue growth. However, premium spirits and emerging market demand might offset some risks. Investors face critical decisions amid mixed signals, weighing whether current prices embed growth prospects or overestimate future earnings.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus
Previous Story

Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street
Next Story

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street

Go toTop